Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNM1 | Q05193 | 9/20 | 0.35 |
| ▸ | TSHR | P16473 | 2/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.35 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.32 |
| ▸ | CA12 | O43570 | 2/20 | 0.30 |
| ▸ | CA1 | P00915 | 2/20 | 0.30 |
| ▸ | CA2 | P00918 | 2/20 | 0.30 |
| ▸ | CA3 | P07451 | 2/20 | 0.30 |
| ▸ | CA4 | P22748 | 2/20 | 0.30 |
| ▸ | CA6 | P23280 | 2/20 | 0.30 |
| ▸ | CA5A | P35218 | 2/20 | 0.30 |
| ▸ | CA7 | P43166 | 2/20 | 0.30 |
| ▸ | CA9 | Q16790 | 2/20 | 0.30 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.30 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.30 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | BLM | P54132 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29102096 | 0.98 | DNM1 (0.39) | DNM1TSHRMEN1KMT2AALDH1A1 | |
| SCHEMBL28118623 | 0.84 | CA1 (0.37) | DNM1TSHRMEN1KMT2ACA12 | |
| SCHEMBL27926803 | 0.83 | — | — | |
| SCHEMBL29280230 | 0.82 | CA1 (0.39) | DNM1TSHRMEN1KMT2ACA12 | |
| SCHEMBL22529651 | 0.81 | ADRB2 (0.42) | TSHRALDH1A1CA12CA1CA2 | |
| SCHEMBL27984182 | 0.79 | DNM1 (0.36) | DNM1TSHRMEN1KMT2AALDH1A1 | |
| SCHEMBL27539917 | 0.79 | NFKB1 (0.33) | DNM1TSHRMEN1KMT2AALDH1A1 | |
| SCHEMBL28460026 | 0.77 | DNM1 (0.40) | DNM1TSHRMEN1KMT2AALDH1A1 | |
| SCHEMBL28873 | 0.77 | KMT2A (0.30) | KMT2A | |
| SCHEMBL27687884 | 0.76 | DNM1 (0.33) | DNM1TSHRMEN1KMT2AALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7928191-B2 | Method for purifying bioactive substances | FUJIFILM CORPORATION (JP) | 2011-04-19 | — | — | US | disclosed |
| US-20090062515-A1 | METHOD FOR PURIFYING BIOACTIVE SUBSTANCES | FUJIFILM CORPORATION (JP) | 2009-03-05 | — | — | US | disclosed |
| EP-2031394-A1 | Method for purifying bioactive substances | FUJIFILM Corporation (JP) | 2009-03-04 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090062515-A1 | METHOD FOR PURIFYING BIOACTIVE SUBSTANCES | BMP2, BMP1, BMP4 | DNM1 4191/4885TSHR 2258/4885MEN1 570/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.